Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey North

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Cutaneous Pathology|April 28, 2011
Alpha-interferon induced sarcoidosis mimicking metastatic melanomaJeffrey North, Thaddeus Mully
Dermatology Online Journal|September 12, 2013
Clinical and histopathologic findings in cutaneous sting ray wounds: a case reportDanielle Tartar, Marketa Limova, Jeffrey North
Journal of Cutaneous Pathology|May 19, 2023
The utility of p63, CK7, and CAM5.2 staining in differentiating pagetoid intraepidermal carcinomasRebekah Wieland, Prajesh Adhikari, Jeffrey North
Cutis|May 3, 2018
Postherpetic isotopic responses with 3 simultaneously occurring reactions following herpes zosterAshley M Jenkins, Daniel Skinner, Jeffrey North
Current Pharmaceutical Design|November 20, 2013
New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeuticsE Jeffrey North, Mary Jackson, Richard E Lee
The American Journal of Dermatopathology|August 28, 2020
Quantitative Assessment of Eosinophils in Dermatomyositis Skin Biopsies With Correlation of Eosinophils to Pruritus and Other Clinical FeaturesUrmi Khanna, Heidi Vaughan, Jeffrey North, et al.
Tetrahedron Letters|October 7, 2017
A Simple and Efficient Approach for the Synthesis of 2-Aminated Quinazoline Derivatives via Metal Free Oxidative AnnulationAmit N Pandya, Eric M Villa, E Jeffrey North
Results in Chemistry|February 23, 2026
Pre-formulation development of highly potent nontuberculous mycobacterial agentsSatish G Agrawal, E Jeffrey North, Alekha K Dash
International Journal of Molecular Sciences|September 2, 2020
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial InfectionsJigar P Sethiya, Melanie A Sowards, Mary Jackson, et al.
Expert Opinion on Drug Discovery|May 25, 2023
Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infectionsE Jeffrey North, Chris P Schwartz, Helen I Zgurskaya, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Cutaneous Pathology|April 28, 2011
Alpha-interferon induced sarcoidosis mimicking metastatic melanomaJeffrey North, Thaddeus Mully
Dermatology Online Journal|September 12, 2013
Clinical and histopathologic findings in cutaneous sting ray wounds: a case reportDanielle Tartar, Marketa Limova, Jeffrey North
Journal of Cutaneous Pathology|May 19, 2023
The utility of p63, CK7, and CAM5.2 staining in differentiating pagetoid intraepidermal carcinomasRebekah Wieland, Prajesh Adhikari, Jeffrey North
Cutis|May 3, 2018
Postherpetic isotopic responses with 3 simultaneously occurring reactions following herpes zosterAshley M Jenkins, Daniel Skinner, Jeffrey North
Current Pharmaceutical Design|November 20, 2013
New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeuticsE Jeffrey North, Mary Jackson, Richard E Lee
The American Journal of Dermatopathology|August 28, 2020
Quantitative Assessment of Eosinophils in Dermatomyositis Skin Biopsies With Correlation of Eosinophils to Pruritus and Other Clinical FeaturesUrmi Khanna, Heidi Vaughan, Jeffrey North, et al.
Tetrahedron Letters|October 7, 2017
A Simple and Efficient Approach for the Synthesis of 2-Aminated Quinazoline Derivatives via Metal Free Oxidative AnnulationAmit N Pandya, Eric M Villa, E Jeffrey North
Results in Chemistry|February 23, 2026
Pre-formulation development of highly potent nontuberculous mycobacterial agentsSatish G Agrawal, E Jeffrey North, Alekha K Dash
International Journal of Molecular Sciences|September 2, 2020
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial InfectionsJigar P Sethiya, Melanie A Sowards, Mary Jackson, et al.
Expert Opinion on Drug Discovery|May 25, 2023
Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infectionsE Jeffrey North, Chris P Schwartz, Helen I Zgurskaya, et al.
Pageof 4